当前位置:首页 - 行情中心 - 南新制药(688189) - 财务分析 - 现金流量表

南新制药

(688189)

  

流通市值:27.85亿  总市值:27.85亿
流通股本:2.74亿   总股本:2.74亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金26,705,887.25279,702,507.35186,545,063.1164,459,677.19
  收到的税费返还267.65192,084.96204,856.6712,771.71
  收到其他与经营活动有关的现金1,681,365.078,245,819.9218,955,390.1216,153,936.8
  经营活动现金流入小计28,387,519.97288,140,412.23205,705,309.89180,626,385.7
  购买商品、接受劳务支付的现金7,242,312.2628,825,693.6826,146,015.5119,459,516.16
  支付给职工以及为职工支付的现金13,563,820.0458,504,319.2441,088,371.9827,397,524.1
  支付的各项税费2,696,560.718,832,297.458,022,938.735,846,837.49
  支付其他与经营活动有关的现金16,763,484.6377,405,989.5355,224,920.1645,646,876.12
  经营活动现金流出小计40,266,177.64173,568,299.9130,482,246.3898,350,753.87
  经营活动产生的现金流量净额-11,878,657.67114,572,112.3375,223,063.5182,275,631.83
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额-4,561,451.24,397,839.722,938,741.45
  收到的其他与投资活动有关的现金-150,000,000150,000,000-
  投资活动现金流入的平衡项目-000
  投资活动现金流入小计-154,561,451.2154,397,839.722,938,741.45
  购建固定资产、无形资产和其他长期资产支付的现金8,399,521.979,802,045.4867,642,925.8963,872,061.3
  支付其他与投资活动有关的现金30,000,000150,000,000150,000,000150,000,000
  投资活动现金流出小计38,399,521.9229,802,045.48217,642,925.89213,872,061.3
  投资活动产生的现金流量净额-38,399,521.9-75,240,594.28-63,245,086.17-210,933,319.85
三、筹资活动产生的现金流量:
  取得借款收到的现金-10,000,000--
  收到其他与筹资活动有关的现金-25,269.26--
  筹资活动现金流入平衡项目-0--
  筹资活动现金流入小计-10,025,269.26--
  偿还债务支付的现金-219,000,00070,000,00070,000,000
  分配股利、利润或偿付利息支付的现金45,0002,707,099.982,210,266.65-
  支付其他与筹资活动有关的现金3,108,441.9121,548,200.087,374,877.662,227,871.66
  筹资活动现金流出小计3,153,441.91243,255,300.0679,585,144.3172,227,871.66
  筹资活动产生的现金流量净额-3,153,441.91-233,230,030.8-79,585,144.31-72,227,871.66
五、现金及现金等价物净增加额-53,431,621.48-193,898,512.75-67,607,166.97-200,885,559.68
  加:期初现金及现金等价物余额296,371,762.62490,270,275.37490,270,275.37490,270,275.37
  期末现金及现金等价物余额242,940,141.14296,371,762.62422,663,108.4289,384,715.69
补充资料:
  净利润--149,754,778.63--43,826,515.3
  资产减值准备-41,539,582.46-3,555,852.62
  固定资产和投资性房地产折旧-19,845,218.28-9,928,006.42
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-19,845,218.28-9,928,006.42
  无形资产摊销-15,826,193.99-8,160,979.78
  长期待摊费用摊销-45,114.4-19,025.39
  处置固定资产、无形资产和其他长期资产的损失--2,526,385.47--
  固定资产报废损失-6,423.74--
  财务费用-3,575,685.32-1,448,716.65
  投资损失---275,386.3
  递延所得税-17,213,899.86--129,469.06
  其中:递延所得税资产减少-17,213,899.86--24,278.18
    递延所得税负债增加----105,190.88
  存货的减少-28,159,988.27-7,369,859.2
  经营性应收项目的减少-178,317,460.62-120,486,584.89
  经营性应付项目的增加--76,046,694.62--35,807,719.48
  其他-22,868,894.84--
  现金的期末余额-296,371,762.62-289,384,715.69
  减:现金的期初余额-490,270,275.37-490,270,275.37
  现金及现金等价物的净增加额--193,898,512.75--200,885,559.68
公告日期2026-04-302026-04-302025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑